According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,03ย โฌ. In 2023 the company made an earnings per share (EPS) of -1,03ย โฌ a decrease over its 2022 EPS that were of -1,01ย โฌ.